amylin glp 1 receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine Combined GLP-1/amylin analog bests monotherapy
Description
doi: 10.1111/apt.15316
These findings from diverse PRS studies illustrate both the potential and the inherent challenges in using genetic scores to elucidate the link between MDD and T2DM
Not only does this treatment failure burden the healthcare system with excess costs, it can also be devastating for patients who end up right back where they started
Which of these patient-specific factors (e.g., BMI, A1C, comorbidities) make this patient a good candidate for semaglutide
